Related Experiment Video
Updated: Jan 20, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides
Biao Chen1, Yan Zheng1, Jingna Zhu1
1Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Abstract:
Mycosis Fungoides (MF) is the most common subtype of cutaneous T-cell lymphomas (CTCL). Shank-associated RH domain-interacting protein (SHARPIN) participates in the initiation and development of multiple tumors. However, the clinical significance of SHARPIN in MF hasn't been investigated. The c-Jun N-terminal kinases (JNKs) pathway is a member of mitogen-activated protein kinases (MAPKs). Its dysregulation is observed in various tumors including CTCL, whereas the roles of JNKs pathway in MF remain largely unknown, the relationship between SHARPIN and JNKs pathway remains elusive. Herein, we showed that upregulated expression of SHARPIN was related to poor prognosis of MF patients. In vitro experiments found increased SHARPIN expression and activation of JNKs pathway in MF cell line MyLa2059. SHARPIN induced transforming growth factor β activated kinase-1 (TAK1) transcription, which is an upstream kinase of JNKs, NF-κB and p38 pathway, leading to activation of JNKs and NF-κB pathway. SHARPIN also promoted p38 signalling independent of TAK1 expression, by which overexpression of SHARPIN induced cell proliferation, inhibited apoptosis, enhanced migration and invasion of MyLa2059. Our work provided direct evidences for effects of SHARPIN on JNKs and NF-κB pathway, and the contributing roles of JNKs, NF-κB and p38 pathway regulated by SHARPIN in the development of MF.
Insights
Shank-associated RH domain-interacting protein (SHARPIN) upregulation correlates with poor prognosis in Mycosis Fungoides (MF), a type of cutaneous T-cell lymphoma (CTCL). SHARPIN activates key signaling pathways, promoting MF cell growth and spread.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL).
- Shank-associated RH domain-interacting protein (SHARPIN) is implicated in tumor development, but its role in MF is unknown.
- The c-Jun N-terminal kinases (JNKs) pathway is dysregulated in CTCL, yet its specific role in MF and its relationship with SHARPIN remain unclear.
Purpose of the Study:
- To investigate the clinical significance of SHARPIN in MF.
- To elucidate the relationship between SHARPIN and the JNKs pathway in MF.
- To determine the molecular mechanisms by which SHARPIN influences MF progression.
Main Methods:
- Analysis of SHARPIN expression in MF patients and correlation with prognosis.
- In vitro studies using the MF cell line MyLa2059.
- Investigation of SHARPIN's effects on signaling pathways including JNKs, NF-κB, p38, and TAK1.
Main Results:
- Upregulated SHARPIN expression is associated with poor prognosis in MF patients.
- SHARPIN expression and JNKs pathway activation are increased in MF cells (MyLa2059).
- SHARPIN induces transforming growth factor β activated kinase-1 (TAK1) transcription, activating JNKs and NF-κB pathways.
- SHARPIN independently promotes p38 signaling, leading to increased cell proliferation, migration, and invasion, while inhibiting apoptosis in MyLa2059 cells.
Conclusions:
- SHARPIN upregulation is a potential biomarker for poor prognosis in MF.
- SHARPIN plays a significant role in MF development by activating JNKs, NF-κB, and p38 signaling pathways.
- Targeting SHARPIN or its downstream pathways may offer therapeutic strategies for MF.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
13:04Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
The Eukaryotic Promoter Region
08:47Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
07:09Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
